domingo, 13 de septiembre de 2026

Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

News articleYahoo Finance· January 21, 2026

Altman pursues Middle East capital as OpenAI seeks $800 billion valuation - Report

View original at finance.yahoo.com

Altman pursues Middle East capital as OpenAI seeks $800 billion valuation - Report Investing.com -- OpenAI Chief Executive Officer Sam Altman has been meeting with top investors in the Middle East to line up funding for a new investment round…

Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

OpenAI is seeking at least $50 billion in a new investment round
90% confidence
OpenAI held discussions with Amazon to raise at least $10 billion
90% confidence
OpenAI is aggressively pursuing tens of billions in new capital
85% confidence
OpenAI is aiming for a valuation between $750 billion and $830 billion
85% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página

En vivo desde el sustrato

Lo que estamos viendo

AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist

AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.

Nuestra lectura de los datos ›

Señales que seguimos

EPKINLY Regulatory-Clinical Success Cascade

High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

Patrones que observamos ›

Donde las fuentes discrepan

ING Group

Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.

Señalamos los conflictos abiertamente ›

Verificado recientemente

✓ Verificado con la fuente original

4,981

hechos rastreados a su fuente — y señalamos los que no se sostienen.

101 entidades seguidas4,981 hechos verificados con la fuente5,280 documentos fuente archivados

Consulta estos datos → isubstrate.com